The discovery of dopamine deficiency in the parkinsonian brain.
about
Diagnosis of Parkinson's disease based on disease-specific autoantibody profiles in human seraUpdate on the treatment of Parkinson’s disease psychosis: role of pimavanserinSparse but selective and potent synaptic transmission from the globus pallidus to the subthalamic nucleus.Dopamine signaling is essential for precise rates of locomotion by C. elegans.A genomics approach identifies selective effects of trans-resveratrol in cerebral cortex neuron and glia gene expression.Monitoring the Level of 14C-Labelled Selegiline Following Oral AdministrationAn evidence-based exercise regimen for patients with mild to moderate Parkinson's disease.Manganese and Parkinson's disease: a critical review and new findings.Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease.Effects of the beta-adrenergic receptor antagonist Propranolol on dyskinesia and L-DOPA-induced striatal DA efflux in the hemi-parkinsonian ratPrevalence and risk factors of cognitive impairment in Parkinson disease: a population-based case-control study in Taiwan.The subthalamic nucleus is one of multiple innervation sites for long-range corticofugal axons: a single-axon tracing study in the rat.Dynamic systems approaches and levels of analysis in the nervous system.Subcellular Patch-clamp Recordings from the Somatodendritic Domain of Nigral Dopamine Neurons.Vulnerability of mesostriatal dopaminergic neurons in Parkinson's diseaseSequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.Longitudinal changes of cortical microstructure in Parkinson's disease assessed with T1 relaxometryThe ER retention protein RER1 promotes alpha-synuclein degradation via the proteasome.Ca(2+)/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome.Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson's Disease.D2-like dopamine receptor-mediated modulation of activity-dependent plasticity at GABAergic synapses in the subthalamic nucleus.Phosphorylated α-Synuclein-Copper Complex Formation in the Pathogenesis of Parkinson's Disease.Adenosine A2A Receptor Antagonists in Neurodegenerative Diseases: Huge Potential and Huge Challenges.
P2860
Q28731824-13240B8B-5BF9-41C5-BB88-93417851B8B6Q29048641-9613BDFB-BFC8-4201-8443-058AB5725C72Q30488881-F6E424F4-CF44-488E-965D-54E5F6F25830Q31066332-7B0D44B6-A2BE-43E3-8B11-4C05635139CFQ33602768-EB05D273-8BB8-432D-8C6A-BE1A37C4C6CEQ33641412-A6752819-64CE-471A-BB4D-D14287C86485Q33772070-B8496AB1-EFAF-4335-9E4A-710163838730Q34060040-1DA89B13-9190-42E3-8DEF-0972DB677D01Q34673305-7966506B-3656-44B2-88B9-E16A9025F3FFQ35815701-A6AE306B-4273-428C-92EE-2E00391173F9Q36153715-EDC6CA2C-12F6-47ED-BA1F-27DBCCD6F2CAQ36343150-8C679A48-0947-4F44-A84B-AD422DA77524Q36586662-91DA3AD3-D7D1-401C-9B4B-32E1061C7AD2Q37579801-C72B2C63-F3A0-46B6-8175-8BA0A4021223Q37809751-0DE2FCA2-4B14-4067-93E6-0229C9380F7CQ38434567-E1CB227F-7E90-4D64-A332-631A2E729ABAQ38766599-E159CF95-8F6C-429B-923C-964B775CDE56Q41635176-0D8D5861-DB74-4F4C-B11D-B229DE84CD49Q41836063-F7F55183-1C6C-4E9E-96B8-B6647BD7CE98Q41954719-0422848F-197A-4890-8F6A-241A2F9E0930Q46740195-B13A5F43-B8AB-439C-A0AB-699A5BE30ADDQ48246699-2F0F8C47-51D7-4031-952C-747CD003EAD4Q55297865-A88590CA-BE8B-4EA7-8074-28A63009F9C2
P2860
The discovery of dopamine deficiency in the parkinsonian brain.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The discovery of dopamine deficiency in the parkinsonian brain.
@ast
The discovery of dopamine deficiency in the parkinsonian brain.
@en
type
label
The discovery of dopamine deficiency in the parkinsonian brain.
@ast
The discovery of dopamine deficiency in the parkinsonian brain.
@en
prefLabel
The discovery of dopamine deficiency in the parkinsonian brain.
@ast
The discovery of dopamine deficiency in the parkinsonian brain.
@en
P1476
The discovery of dopamine deficiency in the parkinsonian brain.
@en
P2093
Hornykiewicz O
P577
2006-01-01T00:00:00Z